从COVID前到COVID后的药物治疗:长期趋势和长期COVID症状的预测指标
Nadia Baalbaki1,2,3, Sien T Verbeek1, Harm Jan Bogaard1,4
1Department of Pulmonary Medicine, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.
Biomedicines
|January 8, 2025
概括
在COVID-19之前的药物历史可以表明长期的COVID症状. 前COVID呼吸道药物与疲劳相关,而抗感染药物和心血管药物与较少的症状有关.
科学领域:
- 药物治疗趋势和长期COVID预测.
- 在COVID-19的急性后遗症中提供个性化医疗.
背景情况:
- 长期COVID在急性感染后呈现持续症状,缺乏经批准的治疗方法.
- 由于长期COVID的异质性,个性化医疗至关重要.
研究的目的:
- 描述从COVID前到COVID后阶段的药物治疗趋势.
- 评估COVID前药疗是否预测长期COVID症状作为健康状况指标.
主要方法:
- 对95名长期COVID患者在COVID前,急性COVID和COVID后阶段的药物治疗模式的描述性分析.
- 回归分析检查COVID前药物和长期COVID结果之间的关联.
主要成果:
- 药物使用在急性COVID期间达到峰值,皮质类固醇和抗血栓剂增加,氨酸- ангиотензин系统抑制剂减少.
- 在所有阶段都观察到食道药物的持续使用.
- 前COVID呼吸道药物与疲劳相关;抗感染药物和心血管药物与较少的症状类别相关.
结论:
- 药物治疗趋势为COVID-19治疗提供了纵向洞察力.
- 前COVID药物历史作为个性化长期COVID管理的有价值的健康状况指标.
更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.6K
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
4.6K
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:20Chronopharmacokinetics: Time-Dependent Pharmacokinetics
83
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
83
01:26Longitudinal Studies
128
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
128
01:19Pharmacovigilance
771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771
01:26Drug Administration and Therapy Phases: Overview
406
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
406